Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.

Mitchell B Berger1, Jeannine M Mendrola, Mark A Lemmon

  • 1Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6059, USA.

FEBS Letters
|July 1, 2004
PubMed
Summary

Neuregulin (NRG) receptor ErbB3/HER3 does not form homodimers upon ligand binding. This suggests ErbB3 requires a heterodimerization partner, like ErbB2, for signaling, impacting cancer research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An S752D activation loop mutation dynamically primes Muscle-Specific Kinase for activation.

The Biochemical journal·2026
Same author

Lipids regulate epidermal growth factor receptor activation by its ligands.

Biochemical Society transactions·2026
Same author

The role of kinase domain dimerization in EGFR activation.

Structure (London, England : 1993)·2025
Same author

Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling.

eLife·2024
Same author

Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes.

Cell reports·2023
Same author

Glycoproteomic landscape and structural dynamics of TIM family immune checkpoints enabled by mucinase SmE.

Nature communications·2023

Area of Science:

  • Cellular signaling pathways
  • Receptor tyrosine kinase biology
  • Cancer cell communication

Background:

  • Neuregulin (NRG) signaling via ErbB3/HER3 is crucial for cell growth and survival.
  • Understanding ErbB3 receptor dimerization is key to elucidating its signaling mechanisms.
  • Previous biophysical data indicated ErbB3's extracellular domain remains monomeric upon NRG binding.

Purpose of the Study:

  • To investigate whether ErbB3 forms homodimers upon neuregulin (NRG) ligand binding in living cells.
  • To determine the dimerization requirements for ErbB3/HER3 receptor activation.
  • To clarify ErbB3's role as a signaling partner in the ErbB receptor network.

Main Methods:

  • Utilized a chimeric receptor strategy, fusing the ErbB3 extracellular domain to the ErbB1 intracellular kinase domain.

Related Experiment Videos

  • Co-expressed chimeric receptors with ErbB2 and/or ErbB4 in living cells.
  • Assessed receptor activation in response to neuregulin (NRG) stimulation.

    • Main Results:

    • The ErbB3/ErbB1 chimera required co-expression of ErbB2 for activation by NRG.
    • In contrast, an ErbB4/ErbB1 chimera activated without requiring ErbB2 co-expression.
    • These findings indicate ErbB3's inability to homodimerize and activate.

    Conclusions:

    • ErbB3/HER3 functions as an obligate heterodimerization partner.
    • ErbB3 requires interaction with other ErbB family members, particularly ErbB2, for signal transduction.
    • This clarifies ErbB3's unique role in mediating neuregulin signaling pathways.